These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12162500)

  • 1. Autosomal dominant hypocalcemia caused by a novel mutation in the loop 2 region of the human calcium receptor extracellular domain.
    Hu J; Mora S; Colussi G; Proverbio MC; Jones KA; Bolzoni L; De Ferrari ME; Civati G; Spiegel AM
    J Bone Miner Res; 2002 Aug; 17(8):1461-9. PubMed ID: 12162500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor.
    Hu J; Mora S; Weber G; Zamproni I; Proverbio MC; Spiegel AM
    J Bone Miner Res; 2004 Apr; 19(4):578-86. PubMed ID: 15005845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.
    Pearce SH; Williamson C; Kifor O; Bai M; Coulthard MG; Davies M; Lewis-Barned N; McCredie D; Powell H; Kendall-Taylor P; Brown EM; Thakker RV
    N Engl J Med; 1996 Oct; 335(15):1115-22. PubMed ID: 8813042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia.
    Conley YP; Finegold DN; Peters DG; Cook JS; Oppenheim DS; Ferrell RE
    Mol Genet Metab; 2000 Dec; 71(4):591-8. PubMed ID: 11136551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a calcimimetic compound and naturally activating mutations on the human Ca2+ receptor and on Ca2+ receptor/metabotropic glutamate chimeric receptors.
    Hauache OM; Hu J; Ray K; Xie R; Jacobson KA; Spiegel AM
    Endocrinology; 2000 Nov; 141(11):4156-63. PubMed ID: 11089548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.
    Pollak MR; Brown EM; Estep HL; McLaine PN; Kifor O; Park J; Hebert SC; Seidman CE; Seidman JG
    Nat Genet; 1994 Nov; 8(3):303-7. PubMed ID: 7874174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
    Nagase T; Murakami T; Tsukada T; Kitamura R; Chikatsu N; Takeo H; Takata N; Yasuda H; Fukumoto S; Tanaka Y; Nagata N; Yamaguchi K; Akatsu T; Yamamoto M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2681-7. PubMed ID: 12050233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger.
    Brown EM; Chattopadhyay N; Vassilev PM; Hebert SC
    Recent Prog Horm Res; 1998; 53():257-80; discussion 280-1. PubMed ID: 9769711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling of calcium receptors to inositol phosphate and cyclic AMP generation in mammalian cells and Xenopus laevis oocytes and immunodetection of receptor protein by region-specific antipeptide antisera.
    Chang W; Pratt S; Chen TH; Nemeth E; Huang Z; Shoback D
    J Bone Miner Res; 1998 Apr; 13(4):570-80. PubMed ID: 9556057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.
    Ward BK; Magno AL; Blitvich BJ; Rea AJ; Stuckey BG; Walsh JP; Ratajczak T
    Clin Endocrinol (Oxf); 2006 May; 64(5):580-7. PubMed ID: 16649980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating mutations of the Ca2+-sensing receptor.
    Mancilla EE; De Luca F; Baron J
    Mol Genet Metab; 1998 Jul; 64(3):198-204. PubMed ID: 9719629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.
    Okazaki R; Chikatsu N; Nakatsu M; Takeuchi Y; Ajima M; Miki J; Fujita T; Arai M; Totsuka Y; Tanaka K; Fukumoto S
    J Clin Endocrinol Metab; 1999 Jan; 84(1):363-6. PubMed ID: 9920108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor.
    Tan YM; Cardinal J; Franks AH; Mun HC; Lewis N; Harris LB; Prins JB; Conigrave AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):605-10. PubMed ID: 12574188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
    Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domains determining ligand specificity for Ca2+ receptors.
    Hammerland LG; Krapcho KJ; Garrett JE; Alasti N; Hung BC; Simin RT; Levinthal C; Nemeth EF; Fuller FH
    Mol Pharmacol; 1999 Apr; 55(4):642-8. PubMed ID: 10101021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.
    Park SY; Mun HC; Eom YS; Baek HL; Jung TS; Kim CH; Hong S; Lee S
    Clin Endocrinol (Oxf); 2013 May; 78(5):687-93. PubMed ID: 23009664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Ca(2+)-sensing receptor mutation causes hypoparathyroidism by increasing receptor sensitivity to Ca2+ and maximal signal transduction.
    Mancilla EE; De Luca F; Ray K; Winer KK; Fan GF; Baron J
    Pediatr Res; 1997 Oct; 42(4):443-7. PubMed ID: 9380434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells missing-2 (GCM2) transactivates the calcium-sensing receptor gene: effect of a dominant-negative GCM2 mutant associated with autosomal dominant hypoparathyroidism.
    Canaff L; Zhou X; Mosesova I; Cole DE; Hendy GN
    Hum Mutat; 2009 Jan; 30(1):85-92. PubMed ID: 18712808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene.
    Sato K; Hasegawa Y; Nakae J; Nanao K; Takahashi I; Tajima T; Shinohara N; Fujieda K
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3068-73. PubMed ID: 12107202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.